CRBU - Company ID 0001619856
The table below shows Caribou Biosciences, Inc.'s balance sheet line items across its last 5 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Cash & equivalents | $12.36M | $16.29M | $51.16M | $58.34M | $240.42M |
| Short-term investments | - | - | - | - | $0.00 |
| Receivables | $69.00K | $265.00K | $148.00K | $202.00K | $1.15M |
| Inventory | - | - | - | - | - |
| Total current assets | $145.23M | $219.38M | $338.84M | $260.25M | $391.19M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Property, plant & equipment | $6.76M | $19.28M | $18.27M | $10.68M | $4.89M |
| Goodwill | - | - | - | - | - |
| Total assets | $175.37M | $313.31M | $432.21M | $373.76M | $442.36M |
| Accounts payable | $5.78M | $2.48M | $3.12M | $1.15M | $3.99M |
| Total current liabilities | $25.41M | $30.65M | $28.30M | $28.13M | $25.83M |
| Long-term debt | - | - | - | - | - |
| Total liabilities | $53.19M | $60.36M | $63.81M | $72.89M | $54.53M |
| Retained earnings | -$596.51M | -$448.39M | -$299.29M | -$197.22M | -$97.79M |
| Total equity | $122.17M | $252.95M | $368.40M | $300.87M | $387.82M |